First Horizon Advisors’s Integra LifeSciences IART Stock Holding History

First Horizon Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-420	Closed	-$12.2K	–	2352
2024 Q2	$12.2K	Sell	420 -110	-21%	-$3.26K	﹤0.01%	1449
2024 Q1	$18.8K	Hold	530	–	–	﹤0.01%	1361
2023 Q4	$23.1K	Hold	530	–	–	﹤0.01%	1278
2023 Q3	$20.2K	Sell	530 -732	-58%	-$30.8K	﹤0.01%	1250
2023 Q2	$51.9K	Buy	1,262 +207	+20%	+$9.96K	﹤0.01%	867
2023 Q1	$60.6K	Buy	1,055 +34	+3%	+$1.92K	﹤0.01%	807
2022 Q4	$57.2K	Buy	1,021 +15	+1%	+$763	﹤0.01%	809
2022 Q3	$42K	Hold	1,006	–	–	﹤0.01%	907
2022 Q2	$54K	Buy	+1,006	New	+$60.4K	﹤0.01%	904
2022 Q1	–	Sell	-1,189	Closed	-$79K	–	1980
2021 Q4	$79K	Sell	1,189 -364	-23%	-$24.6K	﹤0.01%	762
2021 Q3	$105K	Buy	1,553 +7	+0.5%	+$495	﹤0.01%	662
2021 Q2	$105K	Sell	1,546 -97	-6%	-$6.86K	0.01%	539
2021 Q1	$113K	Buy	1,643 +28	+2%	+$1.9K	0.01%	477
2020 Q4	$104K	Hold	1,615	–	–	0.01%	424
2020 Q3	$76K	Buy	1,615 +211	+15%	+$10K	0.01%	450
2020 Q2	$65K	Sell	1,404 -6	-0.4%	-$295	0.01%	465
2020 Q1	$62K	Buy	1,410 +583	+70%	+$30.6K	0.01%	445
2019 Q4	$48K	Hold	827	–	–	﹤0.01%	582
2019 Q3	$49K	Hold	827	–	–	﹤0.01%	556
2019 Q2	$46K	Hold	827	–	–	﹤0.01%	594
2019 Q1	$46K	Buy	827 +33	+4%	+$1.68K	﹤0.01%	544
2018 Q4	$35K	Hold	794	–	–	﹤0.01%	594
2018 Q3	$52K	Hold	794	–	–	﹤0.01%	565
2018 Q2	$51K	Hold	794	–	–	﹤0.01%	568
2018 Q1	$43K	Hold	794	–	–	﹤0.01%	534
2017 Q4	$39K	Hold	794	–	–	﹤0.01%	586
2017 Q3	$40K	Hold	794	–	–	﹤0.01%	551
2017 Q2	$39K	Sell	794 -728	-48%	-$34.8K	﹤0.01%	551
2017 Q1	$67K	Buy	1,522 +260	+21%	+$11.1K	0.01%	461
2016 Q4	$51K	Hold	1,262	–	–	0.01%	526
2016 Q3	$51K	Hold	1,262	–	–	0.01%	520
2016 Q2	$50K	Hold	1,262	–	–	0.01%	522
2016 Q1	$45K	Buy	1,262 +250	+25%	+$7.79K	0.01%	566
2015 Q4	$34K	Sell	1,012 -1,482	-59%	-$46.3K	0.01%	575
2015 Q3	$74K	Sell	2,494 -349	-12%	-$10.9K	0.01%	440
2015 Q2	$77K	Sell	2,843 -61	-2%	-$1.63K	0.01%	448
2015 Q1	$73K	Hold	2,904	–	–	0.01%	464
2014 Q4	$64K	Buy	2,904 +1,803	+164%	+$36.6K	0.01%	474
2014 Q3	$22K	Sell	1,101 -39	-3%	-$776	﹤0.01%	789
2014 Q2	$21K	Hold	1,140	–	–	﹤0.01%	812
2014 Q1	$21K	Buy	1,140 +39	+4%	+$753	﹤0.01%	758
2013 Q4	$21K	Hold	1,101	–	–	﹤0.01%	722
2013 Q3	$18K	Buy	+1,101	New	+$17.7K	﹤0.01%	686

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Horizon Advisors's IART Position: Q3 2024 in Review

First Horizon Advisors sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 420 shares — an estimated $12.2K sold.

First Horizon Advisors first reported a position in IART in Q3 2013 and held it in 43 quarters. The position peaked at $113K in Q1 2021. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

First Horizon Advisors reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
First Horizon Advisors sold 420 Integra LifeSciences shares in Q3 2024, an estimated $12.2K.
First Horizon Advisors first reported a position in Integra LifeSciences in Q3 2013 and held it in 43 quarters.
First Horizon Advisors's Integra LifeSciences position peaked at $113K in Q1 2021.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on First Horizon Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.